Related Experiment Video
Updated: Dec 28, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.3K
TSLP Inhibitors for Asthma: Current Status and Future Prospects
Maria Gabriella Matera1, Paola Rogliani2, Luigino Calzetta2
1Chair of Pharmacology, Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Drugs
|February 21, 2020
Summary
Targeting thymic stromal lymphopoietin (TSLP) offers a promising therapeutic strategy for severe asthma. Novel biologic agents blocking TSLP are under investigation to improve patient symptoms and reduce exacerbations.
Area of Science:
- Immunology
- Respiratory Medicine
- Pharmacology
Background:
- Thymic stromal lymphopoietin (TSLP) is a key cytokine implicated in severe human asthma.
- Targeting TSLP and its signaling pathways presents a potential therapeutic avenue for asthma management.
Purpose of the Study:
- To review the current landscape of TSLP-targeting biologic agents for severe asthma.
- To explore novel therapeutic strategies beyond established adaptive immune system mediators.
Main Methods:
- Review of existing literature on TSLP, asthma, and biologic therapies.
- Analysis of the mechanism of action for anti-TSLP agents like tezepelumab.
- Identification of emerging preclinical TSLP-blocking approaches.
Main Results:
- Tezepelumab, a first-in-class anti-TSLP monoclonal antibody, has shown promising results in Phase II trials for severe asthma.
- Several novel TSLP-targeting agents, including antibody fragments and fusion proteins, are in preclinical development.
- Evidence suggests TSLP inhibition may be more effective for daily symptom control than targeting adaptive immunity.
Conclusions:
- TSLP-targeted therapies, including tezepelumab, represent a significant advancement in severe asthma treatment.
- Ongoing research into novel TSLP-blocking agents holds potential for improved asthma exacerbation amelioration.
- Further clarification is needed to fully define the role and optimal application of TSLP inhibition in severe asthma management.
More Related Videos
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
940
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
940
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
01:20Asthma: Pathogenesis and Management
1.1K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
01:24Antiasthma Drugs: Methylxanthines
1.5K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.5K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.4K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.4K